Current Medicinal Chemistry-Cardiovascular & Hematological Agents

Show Articles
Journal Properties
  • Continued as
    Cardiovascular and Hematological Agents in Medicinal Chemistry
  • Number of Articles
    97
  • ISSN
    1568-0169
  • Main Publisher
    Bentham Science Publishers
  • Publisher
    Bentham Science Publishers Ltd.
  • Indian UGC
  • Indian UGC Name
  • DOAJ (latest)
Description
Current Medicinal Chemistry-Cardiovascular & Hematological Agents serves as a vital platform for scientists and researchers exploring new frontiers in the treatment of cardiovascular and hematological disorders. The journal highlights advances in drug discovery, pharmacological evaluations, and innovative therapeutic strategies aimed at enhancing cardiovascular and hematological health. Key areas of focus include the identification and characterization of novel drug targets, the design and synthesis of lead compounds, and the assessment of their efficacy and safety through pre-clinical and clinical studies. The journal also covers the mechanisms of action of existing and emerging therapeutic agents, providing insights into their impact on cardiovascular function, blood coagulation, and hematopoiesis. Indexed by leading databases, including Scopus, the journal aims to reach medicinal chemists, pharmacologists, cardiologists, hematologists, and other healthcare professionals dedicated to improving patient outcomes. Contributions are encouraged in the form of original research articles, reviews, and short communications that showcase groundbreaking discoveries and translational applications in cardiovascular and hematological medicine. By promoting collaboration and knowledge dissemination, the journal strives to drive innovation and accelerate the development of improved therapies for these life-threatening conditions.